| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2544088 | Journal of the American Pharmacists Association | 2008 | 7 Pages |
Abstract
Current literature indicates that combination therapy is statistically better than monotherapy in smoking cessation treatment as assessed by 3-, 6-, and 12-month abstinence rates. Adverse effects and adherence to combination therapy are similar to monotherapy and placebo.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
sima D. PharmD, Lori A. PharmD, AE-C, TT-S, susan R. PharmD, BCPS, swu-Jane (Adjunct Assistant Professor),